Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 4 Jul 2009):

Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement.

Full Abstract

BACKGROUND: There is substantial evidence that methylphenidate (MPH; Ritalin), is being used by healthy university students for non-medical motives such as the improvement of concentration, alertness, and academic performance. The scope and potential consequences of the non-medical use of MPH upon healthcare and society bring about many points of view. METHODS: To gain insight into key ethical and social issues on the non-medical use of MPH, we examined discourses in the print media, bioethics literature, and public health literature. RESULTS: Our study identified three diverging paradigms with varying perspectives on the nature of performance enhancement. The beneficial effects of MPH on normal cognition were generally portrayed enthusiastically in the print media and bioethics discourses but supported by scant information on associated risks. Overall, we found a variety of perspectives regarding ethical, legal and social issues related to the non-medical use of MPH for performance enhancement and its impact upon social practices and institutions. The exception to this was public health discourse which took a strong stance against the non-medical use of MPH typically viewed as a form of prescription abuse or misuse. Wide-ranging recommendations for prevention of further non-medical use of MPH included legislation and increased public education. CONCLUSION: Some positive portrayals of the non-medical use of MPH for performance enhancement in the print media and bioethics discourses could entice further uses. Medicine and society need to prepare for more prevalent non-medical uses of neuropharmaceuticals by fostering better informed public debates.

 

Author information

Author/s: Forlini, Cynthia (C); Racine, Eric (E);

Affiliation: Neuroethics Research Unit, Institut de recherches cliniques de Montréal, 110 avenue des Pins Ouest, Montréal, Québec, H2W 1R7, Canada. cynthia.forlini(-atsign-)ircm.qc.ca

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

Journal: BMC medical ethics (BMC Med Ethics), published in England. (Language: eng)

Reference: 2009-; vol 10 (issue ) : pp 9

Dates: Created 2009/08/03; Completed 2009/08/10;

PMID: 19580661, status: MEDLINE (last retrieval date: 8/21/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Central Nervous System Stimulants (0) ; Dopamine Uptake Inhibitors (0) ; Methylphenidate (113-45-1)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

12/30/1993
6/28/2008
Higher Relevance Score (100)
Lower Relevance Score (71)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index